American Healthcare REIT, Inc. (AHR)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $13.41B
Last updated: Nov 17, 2026 at 11:05 AM ET
American Healthcare REIT, Inc. (AHR) P/E Ratio & Valuation Multiples
American Healthcare REIT (AHR) trades at 22.8x its 2026 FFO estimate. Its forward P/E is 48.1x. It trades at 4.7x sales and 2.3x book value.
Current Multiples
Its P/FFO of 22.8x uses the 2026 FFO estimate of $2.55 per share. Its enterprise value is 28.6x its EBITDA. Its free cash flow yield is 1.6%.
| Multiple | Value |
|---|---|
| P/FFO (2026 estimate) | 22.8x |
| P/E (trailing) | 33.8x |
| Forward P/E | 48.1x |
| Price to sales | 4.7x |
| Price to book | 2.3x |
| EV/EBITDA | 28.6x |
|---|---|
| Price to FCF | 62.9x |
| EV/FCF | 68.6x |
| PEG | N/A |
| FCF yield | 1.6% |
As of Nov 17, 2026
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About AHR
What is AHR's forward P/E ratio?
American Healthcare REIT has a forward P/E ratio of 48.1x. It trades at 22.8x its 2026 FFO estimate.
Is AHR stock overvalued?
American Healthcare REIT trades at 22.8x its 2026 FFO estimate. GNG's valuation label for AHR is Fairly valued.
What is AHR's price to sales ratio?
American Healthcare REIT has a price to sales ratio of 4.7x.
AHR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors